Can China’s New Criminal Law Deter the Next He Jiankui?
By Shao Bowen,
Sixth Tone
| 03. 12. 2021
The latest edition of China’s criminal law formally came into effect March 1. The updated code includes a range of new legal provisions, from making it a crime to insult Communist Party martyrs, to tougher punishments for those who sexually assault certain minors. Scientists, too, have reason to brush up on their legal knowledge: A new section dedicated to “illegal medical practices” was added beneath Article 336, outlawing “the implantation of genetically edited or cloned human embryos into human or animal bodies, or the implantation of genetically edited or cloned animal embryos into human bodies.”
It’s hard not to draw a connection between the new language and China’s 2018 gene-editing scandal. On Nov. 26, 2018, He Jiankui, a researcher at the Southern University of Science and Technology (SUSTech) in Shenzhen, announced in an interview with The Associated Press that his team had helped a Chinese couple give birth to genetically edited twin girls. The father was HIV-positive, and the embryos’ genomes had been edited in an effort to confer genetic resistance to HIV.
The news quickly kicked off a...
Related Articles
Not the species, certainly, but the Institute of that name, which was founded by transhumanist philosopher Nick Bostrom in 2005 as a research group at Oxford University. According to a recently posted Final Report, its goal was “to pursue the big questions in a transdisciplinary way” by pulling together “researchers from disciplines such as philosophy, computer science, mathematics, and economics.” This evolved before long into the study and promotion of “effective altruism” and “longtermism” as...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...
By Timnit Gebru and Émile P. Torres, First Monday | 04.14.2024
The stated goal of many organizations in the field of artificial intelligence (AI) is to develop artificial general intelligence (AGI), an imagined system with more intelligence than anything we have ever seen. Without seriously questioning whether such a system can...
By Harold Brubaker, The Philadelphia Inquirer | 04.04.2024
Acompany started by University of Pennsylvania scientist Jim Wilson has received FDA approval to test a form of gene editing in infants for the first time in the United States, the company said Thursday.
The Plymouth Meeting company, iECURE, is...